Experimental Drug Boosts Survival In Recurrent Ovarian Cancer
Are You Interested in Starting Your Own Health Related Home Based Business? Please Click Here to Find Out How! New clinical data showed an experimental drug called pertuzumab prolonged the survival time for women with recurrent ovarian cancer, a University of Alabama at Birmingham doctor said recently.The data was presented during a scientific session of the 14th European Cancer Conference held in Barcelona, Spain. The session’s main speaker was Sharmila Makhija, M.D., an associate professor in UAB’s Division of Gynecologic Oncology. [click link for full article]
More: continued here
Popularity: 100% [?]